In 2015, we wrote a review in The Journal of Neurology summarizing the field of
autoantibody-associated neurological diseases. Now, in 2023, we present an update of the …

Abstract Purpose of Review Neurosarcoidosis is a rare manifestation of sarcoidosis that is
challenging to diagnose. Biopsy confirmation of granulomas is not sufficient, as other …

Background We describe a cohort of children with severe myelin oligodendrocyte
glycoprotein (MOG)-IgG-associated cerebral cortical encephalitis (CCE), manifesting with …

Tumefactive demyelinating lesions (TDL), characterized by large (≥ 2 cm) demyelinating
lesions mimicking tumors, are a rare manifestation of the central nervous system …

Differentiating multiple sclerosis (MS) from other relapsing inflammatory autoimmune
diseases of the central nervous system such as neuromyelitis optica spectrum disorder …

Myelin oligodendrocyte glycoprotein (MOG) is expressed on the outermost layer of the
myelin sheath in the central nervous system. Recently, the clinical concept of MOG antibody …

Introduction Acute transverse myelitis (ATM) is a term that encompasses a wide range of
etiologies from immune-mediated to infectious. Management and prognosis differ for each …

Background Live cell-based assay (LCBA) is the gold standard for MOG-IgG detection, and
fixed CBA (FCBA) is a widely used commercial alternative. Recent criteria attributed a …

Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin
oligodendrocytes glycoprotein-antibody disease (MOGAD) are distinct autoimmune …

Background and Objectives To test the performance of the 2023 myelin oligodendrocyte
glycoprotein antibody–associated disease (MOGAD) criteria in adults and children with …